ProfileGDS4718 / 225798_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 57% 96% 44% 54% 56% 47% 54% 60% 56% 59% 63% 47% 43% 40% 70% 65% 54% 39% 67% 52% 64% 60% 60% 63% 51% 60% 38% 49% 43% 48% 74% 53% 48% 56% 64% 31% 67% 59% 97% 63% 41% 75% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6119852
GSM549102patient 115, normal, homogenized [OPG study]5.9498657
GSM549104patient 119, normal, homogenized [OPG study]10.698496
GSM549108patient 138, normal, homogenized [OPG study]5.2426544
GSM549119patient 077, normal, homogenized [OPG study]5.7860454
GSM549133patient 032, cancer, homogenized [OPG study]5.815856
GSM549139patient 042, cancer, homogenized [OPG study]5.3512347
GSM549099patient 107, normal, homogenized [OPG study]5.7612454
GSM549109patient 139, normal, homogenized [OPG study]6.1353660
GSM549110patient 046, normal, homogenized [OPG study]5.8868856
GSM549114patient 063, normal, homogenized [OPG study]5.9852259
GSM549122patient 082, normal, homogenized [OPG study]6.3686463
GSM549134patient 033, cancer, homogenized [OPG study]5.3524347
GSM549136patient 036, cancer, homogenized [OPG study]5.0545243
GSM549140patient 044, cancer, homogenized [OPG study]4.926540
GSM549111patient 047, normal, homogenized [OPG study]6.8724770
GSM549113patient 057, normal, homogenized [OPG study]6.4574665
GSM549132patient 031, cancer, homogenized [OPG study]5.7091254
GSM549137patient 038, cancer, homogenized [OPG study]4.8947439
GSM549142patient 047, cancer, homogenized [OPG study]6.6294467
GSM549100patient 110, normal, homogenized [OPG study]5.6594152
GSM549107patient 135, normal, homogenized [OPG study]6.4042764
GSM549115patient 068, normal, homogenized [OPG study]6.0954560
GSM549116patient 072, normal, homogenized [OPG study]6.1273760
GSM549120patient 078, normal, homogenized [OPG study]6.3249563
GSM549131patient 030, cancer, homogenized [OPG study]5.5450451
GSM549118patient 074, normal, homogenized [OPG study]6.1315460
GSM549129patient 027, cancer, homogenized [OPG study]4.9186338
GSM549123patient 088, normal, homogenized [OPG study]5.4580949
GSM549124patient 006, cancer, homogenized [OPG study]5.1512643
GSM549126patient 015, cancer, homogenized [OPG study]5.4040548
GSM549128patient 025, cancer, homogenized [OPG study]7.3155574
GSM549103patient 117, normal, homogenized [OPG study]5.7496953
GSM549117patient 073, normal, homogenized [OPG study]5.3636748
GSM549138patient 041, cancer, homogenized [OPG study]5.8584756
GSM549141patient 045, cancer, homogenized [OPG study]6.4225264
GSM549130patient 028, cancer, homogenized [OPG study]4.6118431
GSM549101patient 111, normal, homogenized [OPG study]6.6264667
GSM549105patient 128, normal, homogenized [OPG study]6.0392259
GSM549106patient 134, normal, homogenized [OPG study]11.182597
GSM549112patient 048, normal, homogenized [OPG study]6.3268763
GSM549125patient 011, cancer, homogenized [OPG study]5.031641
GSM549127patient 024, cancer, homogenized [OPG study]7.3799475
GSM549135patient 035, cancer, homogenized [OPG study]5.9856758